Data

The use and impact of trastuzumab (Herceptin) for early and late stage HER−2 positive breast cancer in Australia

University of New South Wales
University of New South Wales. Faculty of Medicine. Lowy Cancer Research Centre. Adult Cancer Program (Associated with)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=http://hdl.handle.net/1959.4/004_281&rft.title=The use and impact of trastuzumab (Herceptin) for early and late stage HER−2 positive breast cancer in Australia&rft.identifier=http://hdl.handle.net/1959.4/004_281&rft.publisher=University of New South Wales&rft.description=This project was established to conduct a long−term evaluation of the way in which trastuzumab (Herceptin) is used to treat early and late stage breast cancer in the real world clinical setting. Secondary health data sets were linked to examine all patients receiving trastuzumab since the inception of the Herceptin Program (for late stage disease) in December 2001 and since its listing on the Pharmaceutical Benefits Scheme for early stage disease in October 2006. The data linkages have been set up in such a way that it is possible to track individuals receiving PBS-subsidised trastuzumab for early stage disease and upon disease progression patients receiving the drug via the Herceptin Program for metastatic disease. Data access and linkage was facilitated by Medicare Australia, the administering body of both programs. The study currently has approval for annual data updates until 2015&rft.creator=Anonymous&rft.date=2013&rft.coverage=Australia&rft_rights= Access to the data is subject to originating data custodian approval. Ethics committee approval and other access conditions apply. Contact the Information Officer for more information: info.acp@unsw.edu.au. &rft_subject=Oncology and Carcinogenesis not elsewhere classified&rft_subject=MEDICAL AND HEALTH SCIENCES&rft_subject=ONCOLOGY AND CARCINOGENESIS&rft_subject=Clinical Pharmacology and Therapeutics&rft_subject=PHARMACOLOGY AND PHARMACEUTICAL SCIENCES&rft_subject=Public Health and Health Services not elsewhere classified&rft_subject=PUBLIC HEALTH AND HEALTH SERVICES&rft_subject=Pharmacoepidemiology&rft_subject=Drug treatments&rft_subject=Patterns of cancer care&rft.type=dataset&rft.language=English Access the data

Please use the contact information below to request access to this data.

Contact Information

Street Address:
Adult Cancer Program, Lowy Cancer Research Centre, Faculty of Medicine, The University of New South Wales



Licence & Rights:

view details

Access to the data is subject to originating data custodian approval. Ethics committee approval and other access conditions apply. Contact the Information Officer for more information: info.acp@unsw.edu.au.

Access:

Other view details

Access type: Access by request.

Full description

This project was established to conduct a long−term evaluation of the way in which trastuzumab (Herceptin) is used to treat early and late stage breast cancer in the real world clinical setting. Secondary health data sets were linked to examine all patients receiving trastuzumab since the inception of the Herceptin Program (for late stage disease) in December 2001 and since its listing on the Pharmaceutical Benefits Scheme for early stage disease in October 2006. The data linkages have been set up in such a way that it is possible to track individuals receiving PBS-subsidised trastuzumab for early stage disease and upon disease progression patients receiving the drug via the Herceptin Program for metastatic disease. Data access and linkage was facilitated by Medicare Australia, the administering body of both programs. The study currently has approval for annual data updates until 2015

Notes

Originating source(s): Medicare Australia -[Herceptin Program] [Pharmaceutical Benefits Scheme] [Medical Benefits Scheme] and [Patient/Medicare enrolment data]
Click to explore relationships graph

Spatial Coverage And Location

text: Australia

Identifiers